Table 1.
Advantages | Disadvantages | |
---|---|---|
Glycocapture | • Large reduction of sample complexity when analyzing glycopeptides after PNGaseF release. • Possible with in vivo material |
• Serum-free or serum-depleted medium required |
SPECS | • Compatible with protein and serum supplements in the medium • Facilitates secretome and surfaceome analysis. • Many peptides for quantification |
• No direct protease cleavage site identification (only semitryptic peptides can be used). • Only applicable for sheddases • Not suitable for in vivo analyses |
AHA labeling | • Compatible with protein and serum supplements in the medium • Facilitates secretome and surfaceome analysis • Many peptides for quantification |
• No direct protease cleavage site identification (only semitryptic peptides can be used) • Only applicable for sheddases • Titration of AHA concentration necessary to prevent toxicity • Not suitable yet for in vivo analyses |
Surface Biotinylation | • Efficient pull-down of cell surface proteins • In vivo analyses are possible |
• Secretome analysis difficult • No trypsin cleavage at biotinylated lysines |
Murine CSF | • In vivo • Many peptides for quantification |
• Low sample amount (5–15 μl) • Sampling is difficult (blood or cell contamination) • KO mice or inhibitor treatment of mice is necessary |
TAILS | • Direct identification of protease cleavage sites • Also applicable for soluble proteases (e.g., in vitro incubation of protein lysate with protease of interest) |
• Serum-free or serum-depleted medium required • TAILS is hard to establish (especially C-TAILS) • Few peptides for quantification → Additional whole secretome analysis of labeled peptides potentially required |
COFRADIC | • Direct identification of protease cleavage sites • Also applicable for soluble proteases (e.g., in vitro incubation of protein lysate with protease of interest) |
• Serum-free or serum-depleted medium required • HPLC is required for extensive sample fractionation • Histidine containing peptides are lost in the SCX depletion step • Few peptides for quantification → Additional whole secretome analysis of labeled peptides potentially required |
Subtiligase | • Direct identification of protease cleavage sites • Also applicable for soluble proteases (e.g., in vitro incubation of protein lysate with protease of interest) |
• Serum-free or serum-depleted medium required • Large sample amount required • Few peptides for quantification → Additional whole secretome analysis of labeled peptides potentially required |